Antibody Drug Conjugates Contract Global Market Report 2022: Increase in Research on Antibody Therapeutics Fuels Sector
December 29, 2022 07:13 ET | Research and Markets
Dublin, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Contract Market by Condition, by Linker, and by Region - Global Forecast to 2023-2033" report has been added to ...
Global Monoclonal Antibody Therapeutics Market
$264 Worldwide Monoclonal Antibody Therapeutics Industry to 2027 - Featuring AbbVie, Amgen, Bayer and Biogen Among Others
November 01, 2022 05:28 ET | Research and Markets
Dublin, Nov. 01, 2022 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibody Therapeutics Market (2022-2027) by Source, End-Users, Applications, and Geography, Competitive Analysis and the Impact of...
Global Antibody Therapeutics Market Analysis Report 2022-2027 - Key Manufacturers are Striving to Reduce In-house Operations to Leverage the Capabilities of CDMOs
September 26, 2022 04:38 ET | Research and Markets
Dublin, Sept. 26, 2022 (GLOBE NEWSWIRE) -- The "Global Antibody Therapeutics Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This research service offers an...
emergent logo.jpg
Emergent BioSolutions’ COVID-19 Human Immune Globulin Product Candidate to be Evaluated in NIH-Sponsored Phase 3 Clinical Trial (INSIGHT-012) of Hyperimmune Intravenous Immunoglobulin for Outpatient Treatment of COVID-19
August 25, 2021 06:30 ET | Emergent BioSolutions
NIAID has initiated a Phase 3 clinical trial to evaluate the efficacy and safety of hyperimmune globulin products, including Emergent’s COVID-19 Human Immune Globulin (COVID-HIG), for potential...